Eliem Therapeutics, Inc. (ELYM) Earnings
|
Expand Research on ELYM
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -8.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/4/24 | Q324 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/14/24 | Q224 | -$1.81 | $0.00 | -$1.81 | N/A | N/A | N/A |  | | Details | |
| 5/27/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/20/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/25/24 | Q423 | N/A | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/18/24 | Q423 | N/A | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/11/24 | Q423 | N/A | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A |
